Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $9.01 and traded as high as $9.4115. Aspen Pharmacare shares last traded at $9.4115, with a volume of 100 shares trading hands.
Aspen Pharmacare Stock Performance
The stock’s fifty day moving average is $9.01 and its two-hundred day moving average is $8.30. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.66 and a current ratio of 3.64.
About Aspen Pharmacare
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Further Reading
- Five stocks we like better than Aspen Pharmacare
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
